What's happening
The bill allows out-of-state medical cannabis patients to use their authorization in New York and directs the board to regulate medical cannabis pre-rolls.
Why it matters
Expanding Patient Access. By recognizing out-of-state medical cannabis authorizations, the bill makes it easier for patients visiting or temporarily residing in New York to legally obtain and use their medicine without disruption to their treatment plans.
Encourages Regulatory Consistency. Empowering the board to enter reciprocity agreements with other states could encourage more standardized medical cannabis policies across state lines, reducing confusion for traveling patients and healthcare providers.
Product Safety and Quality Oversight. Requiring the board to regulate medical cannabis pre-rolls means patients can expect clearer standards for these products, potentially increasing safety and consistency compared to less regulated offerings.
Supports Medical Cannabis Market Growth. Both provisions could lead to a broader, more robust medical cannabis market in New York—attracting patients from other states and expanding the range of regulated products available to all medical users.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Out-of-state medical cannabis patients
The bill would recognize their home jurisdiction’s authorization as valid registry identification if they provide legitimate documentation and comply with New York’s medical cannabis limits.
Cannabis Control Board
The bill would require the board to issue regulations implementing recognition of nonresident patients and approving medical cannabis pre-roll products, while allowing reciprocity agreements with other states.
New York medical cannabis producers and dispensaries
The bill would require regulations for approval of pre-roll products in the medical cannabis program and recognize qualifying nonresident patients.
Headline styles
Allow Out-of-State Medical Cannabis
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9218
IN SENATE
May 12, 2022
Introduced by Sen. COONEY -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the cannabis law, in relation to certain medical cannabis reforms
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 32 of the cannabis law is amended by adding a new subdivision 17 to read as follows:
17. A person who is not a resident of this state, but who is authorized to engage in the medical use of cannabis under the laws of his or her state or jurisdiction of residence, is deemed to hold a valid registry identification if the person provides legitimate documentation and abides by the legal limits on the possession, delivery and production of cannabis for medical purposes in this state, as set forth in section thirty-one of this article. The board shall make regulations to implement the provisions of this subdivision and may enter into reciprocity agreements with other states with medical cannabis programs.
§ 2. Section 13 of the cannabis law is amended by adding a new subdivision 7 to read as follows:
7. The board shall promulgate regulations for the approval of pre-roll products in the medical cannabis program.
§ 3. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15858-01-2
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the cannabis law, in relation to certain medical canna- bis reforms
Summary of specific provisions
Section one authorizes certified medical cannabis patients from other states to access New York's medical cannabis program provided they have sufficient documentation.
Section two directs the cannabis control board to approve pre-rolled cannabis products in the medical cannabis program.
Section three provides the effective date.
Justification
Nearly every state in the nation has their own medical cannabis program. New York's program began in 2014 with the passing of the Compassionate Care Act. Since then, the medical cannabis program has undergone signif- icant changes especially with the recent state legalization of adult-use cannabis. As the program was transferred from the Department of Health to the Office of Cannabis Management several changes were made to improve the medical program including waiving the registration fee, allowing for whole flower products to be sold, and removing the list of qualifying conditions. Each of these steps helped improve and expand New York's medical cannabis program.
This bill would allow certified medical cannabis patients from other states to access medical dispensaries provided they present sufficient documentation. States such as Nevada, Michigan, Ohio, and Missouri already allow for reciprocity with other states' medical cannabis programs. New York is one of the most visited states by domestic travel- ers in the country. Additionally, many out-of-state residents from states such as New Jersey and Connecticut commute to work in New York. Residents of other states should continue to have access to medical cannabis products while they are in New York.
This bill also directs the cannabis control board to approve pre-rolls for the medical cannabis program. Pre-rolled cannabis products are the most affordable, and often most effective, form of medical cannabis for many patients. Compared to ground metered flower that is used in dry herb vaporizers, smokeable pre-rolled products can be half the price for patients. As the monthly cost of medical cannabis is prohibitively expensive ($400/month on average), reducing the cost for patients in need is of paramount importance to ensuring access to the medical canna- bis program. Lastly, many medical patients have dexterity challenges that prevent them from being able to grind up and roll their own smokea- ble products.
PRIOR LEGISLATIVE HISTORY
This is a new bill.
Fiscal implication
Increased revenue to the state.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.